Skip to content
Governance Register

← US public companies

Transmedics Group, Inc.

SEC CIK 1756262 · TMDX · last insider filing 2026-06-17

Directors (from insider filings)

NameCapacity as filedFilings
Gunderson Thomas James Director filed 2019 - 2026
Raines Merilee Director filed 2021 - 2026
Tobin James R Director filed 2019 - 2026
Kania Edwin Director filed 2019 - 2026
Lovell Stephanie Director filed 2021 - 2026
Basile Edward M Director filed 2019 - 2026
Weill David Director filed 2019 - 2026
Hassanein Waleed H Director · President & CEO filed 2019 - 2025
Gilbert James Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Forsyth Matthew S. See Remarks filed 2026 - 2026
Corcoran Nicholas See remarks filed 2023 - 2026
Ranganath Anil P. See remarks filed 2023 - 2026
Hernandez Gerardo Chief Financial Officer filed 2024 - 2026
Cecere Giovanni Chief Commercial Officer filed 2026 - 2026
Khayal Tamer I Chief Commercial Officer filed 2019 - 2025
Gordon Stephen Chief Financial Officer filed 2019 - 2024
Provost Miriam VP, Global Regulatory Affairs filed 2019 - 2023
Damme Laura VP, Clinical Affairs filed 2019 - 2023
Carey John F VP of Operations filed 2019 - 2023
Sullivan John F VP of Quality & Engineering filed 2019 - 2021
Godhani Rakesh P. Chief Digital Officer filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.